 The objective of this study is to identification of genetic markers and predictors of antidepressant-induced suicidality in youth depression. Participants who take the standardized pharmacotherapy bupropion or lamotrigine for depression will be observed for 8 weeks. They will do several scales and genetic tests at visit 1 week 0, visit 3 week 4 and visit 4 week 8 